This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
“Privacy” is mentioned over 500 times in the document; “HIPAA,” well over 300. And, there are over 500 mentions of the word, “security.” ” Privacy and security concerns are mainstream among Americans in 2020.
A February 2023 report published by researcher Joanne Kim outlines the results of a two-month study of how data brokers sell sensitive data mental health data collected from mHealth mental health apps. A 2019 study documented that 20% of LatinX smartphone users were more likely to use a health app than Caucasians.
The FDA had a digital health banner day on December 7, announcing one final guidance and two draft guidance documents (with a 60-day comment period). FDA has done a very good job of moving the ball forward, though there is certainly room for improvement, and there is opportunity for comment on two of the three guidance documents announced.
Pivot’s newest study documents how an effective smoking cessation program can turn the tide. The randomized controlled trial, published in JMIR mHealth and uHealth, evaluated health outcomes in 188 adults twelve months after enrollment in either the Pivot program or the NCI’s QuitGuide (“the control arm”). Utley, M.D.,
CMS is the federal agency that administers HIPAA standards and develops Medicaid and Medicare reimbursement policies for telemedicine. HIPAA : HIPAA, or the Health Insurance Portability and Accountability Act , is a healthcare compliance law providing data security and privacy for the safeguarding of patient medical information.
The FDA had a digital health banner day on December 7, announcing one final guidance and two draft guidance documents (with a 60-day comment period). FDA has done a very good job of moving the ball forward, though there is certainly room for improvement, and there is opportunity for comment on two of the three guidance documents announced.
The FDA had a digital health banner day on December 7, announcing one final guidance and two draft guidance documents (with a 60-day comment period). FDA has done a very good job of moving the ball forward, though there is certainly room for improvement, and there is opportunity for comment on two of the three guidance documents announced.
The FDA had a digital health banner day on December 7, announcing one final guidance and two draft guidance documents (with a 60-day comment period). FDA has done a very good job of moving the ball forward, though there is certainly room for improvement, and there is opportunity for comment on two of the three guidance documents announced.
The FDA had a digital health banner day on December 7, announcing one final guidance and two draft guidance documents (with a 60-day comment period). FDA has done a very good job of moving the ball forward, though there is certainly room for improvement, and there is opportunity for comment on two of the three guidance documents announced.
Even if an app were to have a feasibility or efficacy study documented, neither is adequate to establish an evidence base for the app. As with telehealth platforms claiming HIPAA compliance , claims are often suspect. Documenting that training is also suggested.
Virtual clinical trials are leveraging the power of telehealth technologies like remote patient monitoring and wearable mHealth devices to conduct safe and effective research at a lower cost by doing so remotely, as opposed to standard (and expensive) locations like a hospital or university medical center. longitudinal data. convenience.
The FDA has previously released guidance documents on Mobile Medical Apps and General Principles of Software Validation. It will address lingering issues such as multifunctional software (technology which has software qualifying as a medical device combined with that which doesn’t).
For health care privacy, Americans’ HIPAA provisions surely don’t cover personal information that informs health beyond the healthcare claim the way Europeans’ GDPR or the soon-to-be-implemented California Consumer Privacy Act of 2020 do. 2017 – Digital Healthcare at the Inflection Point, a la Mary Meeker.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content